Experimental targeted therapy shows early promise against medulloblastomas, type of childhood brain cancer
Tuesday, June 8, 2010 - 23:31
in Health & Medicine
Researchers have presented findings of a pediatric brain tumor study using an experimental drug that targets the underlying genetic makeup of the tumor. The research focused on a new way to attack the tumors by blocking the Hedgehog pathway that is linked to approximately 20 percent of medulloblastomas.